Targets of senescence in cardiac muscle: insights for regenerative treatments in the aged heart.
Abstract
Despite considerable investment of time and funding, advancement in cardiac regenerative therapies has been slow. Results of large animal and human studies have failed to live up to the expectations of the positive pre-clinical animal studies. There are many reasons to explain the discrepancies, however a key factor is that patients in need of regenerative therapies are mostly aged, being 70 years and older.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper investigates the targets of senescence in cardiac muscle to inform regenerative treatments for the aged heart. This research is relevant as it addresses the underlying mechanisms of aging and seeks to improve regenerative therapies specifically for older populations, which is crucial for longevity research.
Author of this paper? Send a correction.